Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GIC-PECET (Grupo de Investigación Clínica - Programa de Estudio y Control de Enfermedades Tropicales) is a premier research institute and clinical service provider located at the University of Antioquia in Medellín, Colombia. Specializing in neglected tropical diseases, the center provides comprehensive Contract Research Organization (CRO) services, including Phase 1 through Phase 3 clinical trials, epidemiological surveillance, and diagnostic development. GIC-PECET is particularly renowned for its work on cutaneous leishmaniasis, having developed proprietary topical treatments and validated numerous therapeutic protocols in collaboration with the Drugs for Neglected Diseases initiative (DNDi). The organization operates state-of-the-art laboratories and clinical facilities, serving as a critical link for pharmaceutical companies and global health organizations seeking to conduct research in endemic regions of Latin America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GIC-PECET.